The PI3K pathway is a crucial component of cell signaling and is frequently dysregulated in cancer. Mutations and amplifications in the PI3K genes can lead to uncontrolled cell growth and survival, contributing to tumorigenesis. Targeting this pathway can help to halt the progression of cancer and improve patient outcomes.
